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Abstract: Flexible adaptation to the host environment is a critical trait that underpins the success of 13 
numerous microbes. The polymorphic fungus Candida albicans has evolved to persist in the 14 
numerous challenging niches of the human body. The interaction of C. albicans with a mucosal 15 
surface is an essential pre-requisite for fungal colonisation and epitomises the complex interface 16 
between microbe and host. C. albicans exhibits numerous adaptations to a healthy host that permit 17 
commensal colonisation of mucosal surfaces without provoking an overt immune response that 18 
may lead to clearance. Conversely, fungal adaptation to impaired immune fitness at mucosal 19 
surfaces enables pathogenic infiltration into underlying tissues, often with devastating 20 
consequences. This review will summarise our current understanding of the complex interactions 21 
that occur between C. albicans and the mucosal surfaces of the human body. 22 
Keywords: Candida albicans; commensal; pathogen; fungus; mucosal infection; microbiota. 23 
 24 
1. Introduction 25 
The human body provides a multitude of disparate and challenging niches to colonizing 26 
microbes, including the mucosal surfaces of the oropharyngeal, gastrointestinal and vaginal tracts. 27 
Candida albicans has evolved to persist at mucosal surfaces {Hallen-Adams, 2017 #6822;Huffnagle, 28 
2013 #6821} as a benign component of the microbiota, and is superbly adapted to life in the host as a 29 
commensal organism, particularly in the gastrointestinal tract. While frequently colonized by C. 30 
albicans, mucosal surfaces nevertheless play a vital role in host protection and are crucial for the 31 
appropriate initiation and coordination of innate immune responses during infection. However, 32 
under circumstances where host immunity is impaired, C. albicans can transition from a harmless 33 
commensal to a pathogen capable of breaching mucosal barriers, causing deep seated invasive and 34 
life-threatening disseminated infection. 35 
Co-evolution of C. albicans with the human host has resulted in both organisms acquiring the 36 
means to adapt to one another. This co-evolutionary "coin" comprises continual fungal adaptation to 37 
the host on one side, and a perpetual evolution of the host immune response to the fungus on the 38 
other. While the majority of scientific studies have focused on C. albicans hyphae and associated 39 
virulence factors, both yeast and hyphal morphologies contribute to fungal persistence in the host. A 40 
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physical interaction between C. albicans and a mucosal surface is a necessary requirement that 41 
precedes commensal colonisation and pathogenic infiltration. 42 
This review article will examine the numerous events that transpire during the interaction of 43 
C. albicans with the mucosal surfaces of the human body; mechanistic and structural aspects of 44 
adhesion will be considered together with the processes of epithelial internalization, the role of 45 
secreted host and fungal factors, and the acquisition of essential micronutrients. 46 
 47 
2. Adhesion of C. albicans to the epithelium 48 
Adhesion of C. albicans to a mucosal surface is an essential requirement for persistence in the 49 
host, whether it be as a commensal or a pathogen {Calderone, 2001 #6486;Gulati, 2016 #6504}. The 50 
mucosal surfaces of the body are covered with a protective coating of mucous which must be 51 
traversed in order for C. albicans to attach itself to underlying epithelial cells. Indeed, adhesion of C. 52 
albicans to buccal epithelial cells is reduced in the presence of purified mucin {de Repentigny, 2000 53 
#6490}. The majority of initial contact between C. albicans and the host is thought to involve yeast, 54 
with germ tube and hypha formation occurring after initial contact. Yeast cells have evolved a 55 
number of strategies to ensure successful adherence to the host epithelium. Initial interactions 56 
between C. albicans and epithelial cells rely on a number of attractive and repulsive forces, including 57 
van der Waals forces and hydrophobic interactions {Williams, 2013 #6516}. While these passive 58 
forces are by no means the predominant mechanism required for long-term fungal adhesion, they 59 
are nevertheless vital for the initiation of adherence. C. albicans and epithelial cells are considered to 60 
possess a net negative charge, implying a degree of electrostatic repulsion that opposes physical 61 
association {Hobden, 1995 #6505}. Successful contact between C. albicans and epithelial cells is thus 62 
dependent on the sum of attractive forces outweighing those which promote cellular repulsion 63 
{Douglas, 1987 #6491}. Adhesion of yeast cells to epithelial cells positively correlates with the 64 
expression of cell surface hydrophobins {Hazen, 1989 #5536;Hazen, 1990 #6148}, while 65 
cetylpyridinium chloride-induced reduction of cell surface hydrophobicity correlates with 66 
decreased adhesion {Jones, 1995 #6506}. 67 
Once attached to the mucosal surface, the adhesion of C. albicans is further strengthened by 68 
numerous interactions with components of the host extracellular matrix. C. albicans yeast can bind to 69 
human fibronectin {Skerl, 1984 #6514;Klotz, 1991 #6507}, proline-rich salivary proteins {O'Sullivan, 70 
1997 #6511} and carbohydrates that facilitate adhesion to human oesophageal epithelial cells 71 
{Enache, 1996 #6493} and buccal epithelial cells in vitro {Samaranayake, 1982 #6760}. 72 
However, the greatest contribution to fungal adhesion is conferred by the adhesins. The best 73 
studied of the C. albicans adhesins are the agglutinin-like sequence (Als) family of proteins; 74 
consisting of 8 members (Als1p-Als7p and Als9p) which are GPI-linked to the β-1,6-glucans of the 75 
fungal cell wall (reviewed in {Hoyer, 2008 #165}). Als5p mediates the initial adhesion of C. albicans 76 
yeast cells to human buccal epithelial cells, and to patches of threonine, serine, and alanine residues 77 
within fibronectin, type IV collagen and laminin {Gaur, 1997 #6495;Gaur, 1999 #6494;Gaur, 2002 78 
#6761}. A conserved tandem repeat region within Als5p facilitates adhesion to numerous epithelial 79 
ligands and promotes yeast-to-yeast cell aggregation {Rauceo, 2004 #6157;Rauceo, 2006 #6512}. The 80 
conserved amyloid forming sequences of Als5p are  implicated in a transition away from overt 81 
pathogenicity towards gastrointestinal commensalism in vivo {Bois, 2013 #6388} and are important 82 
for coordinating the clustering of adhesins on the C. albicans fungal cell wall, facilitating continued 83 
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fungal adhesion to the host by increasing the likelihood of epithelial cell ligands rebinding to nearby 84 
adhesins should detachment occur {Alsteens, 2010 #6485;Lipke, 2012 #6510}.  85 
Expression of ALS genes differs according to fungal morphology and body site. ALS1-5 and 86 
ALS9 were consistently upregulated in a reconstituted human buccal epithelium model of 87 
mucocutaneous candidiasis, while ALS6 and ALS7 exhibited variable expression. In contrast, ALS1, 88 
ALS2, ALS3 and ALS9 were expressed frequently in clinical specimens of vaginal fluid while 89 
transcripts from ALS4 and ALS5 were detected less frequently {Cheng, 2005 #6488}. This differential 90 
expression not only suggests a degree of functional redundancy between Als adhesins but suggests 91 
specific roles for particular adhesins at different mucosal sites {Dranginis, 2007 #6492}. The factors 92 





Figure 1. Interactions of Candida albicans with host epithelial cells. A) C. albicans yeast cells use the 98 
passive forces of electrostatic attraction and specific genome-encoded factors such as agglutinin-like 99 
sequence 5 (Als5p) to adhere to epithelial cells. Yeast-phase beta glucan is recognized by the 100 
non-classical pattern recognition receptor EphA2 during this initial interaction. Ywp1p is expressed 101 
during yeast-phase growth and has anti-adhesive properties. A host receptor for Ywp1p has not yet 102 
been identified. B) Once attached to the mucosal surface the transition to the hyphal morphology 103 
results in the expression of additional adhesins including Als3p and Hwp1p, which further 104 
consolidate epithelial adhesion by interacting with E-cadherin and acting as a substrate for host 105 
transglutaminase enzymes, respectively. Hyphal beta glucan is also recognized by EphA2 during 106 
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this strengthened adherence. C) Epithelial internalization of C. albicans hyphae is mediated by the 107 
Als3p and Ssa1p invasins which interact with E-cadherin and a heterodimeric receptor complex 108 
comprising the epidermal growth factor receptor (EGFR) and Her2 (EGFR/Her2). C. albicans remains 109 
passive during this process of pathogen-induced endocytosis but may also breach mucosal barriers 110 
directly by active penetration. D) While in contact with the mucosal surface, C. albicans secretes an 111 
arsenal of virulence factors including the peptide toxin candidalysin, secreted aspartic proteinases 112 
(Saps), lipases and phospholipases that facilitate pathogenicity. Msb2p is released into the 113 
extracellular environment to counteract the activity of numerous host antimicrobial peptides. 114 
 115 
Of the Als proteins, Als3p is key in the adherence of C. albicans hyphae to epithelial cells and 116 
the subsequent invasion of host cells. ALS3 is upregulated during infection of oral and vaginal 117 
epithelial cells {Cheng, 2005 #6488;Phan, 2007 #5204;Zhu, 2012 #5617;Murciano, 2012 #2101} while 118 
blocking Als3p or preventing ALS3 expression causes a significant reduction in epithelial adhesion 119 
{Hoyer, 2008 #165;Laforce-Nesbitt, 2008 #6509}.  120 
However, the role of certain Als proteins in C. albicans-epithelial interaction is less clear. For 121 
instance, while deletion of ALS1 caused a significant decrease in fungal adhesion to murine tongue 122 
tissue ex vivo {Kamai, 2002 #5881} reports also suggest that Als1p plays only a minor role in 123 
adhesion, particularly when compared with Als3p {Zhao, 2004 #6786}. Similarly, while deletion of 124 
ALS2 decreased the adhesion of C. albicans to a reconstituted model of human oral epithelium, 125 
deletion of ALS4 in the same model had no effect {Zhao, 2005 #2744}.  126 
Given the degree of functional redundancy observed between adhesins and the inherent 127 
complexity associated with adhesion of C. albicans to a diverse range of host tissues, it is perhaps 128 
unsurprising that the process of adhesion is subject to numerous influential forces. Indeed, several 129 
anti-adhesive factors have been identified which may serve to fine-tune the process of adhesion. 130 
Yeast wall protein 1 (Ywp1p/Pga24p) is a yeast specific GPI-linked glycoprotein that is highly 131 
expressed during yeast but not hyphal growth {Sohn, 2003 #6515}. Deletion studies demonstrate that 132 
yeast cells lacking YWP1 are more adhesive {Granger, 2005 #6498;Granger, 2012 #6477}, suggesting a 133 
role for Ywp1p in the dispersal of yeast, which may facilitate dissemination {Granger, 2012 #6477}. 134 
Deletion of ALS5, ALS6 and ALS7 increase adhesion to epithelial cells, suggesting that these proteins 135 
also possess anti-adhesive properties {Zhao, 2007 #3167}. The major factors that contribute to the 136 
adhesion of C. albicans hyphae to epithelial cells are depicted in Figure 1B. 137 
 138 
3. Structural and mechanistic aspects of adhesion to the epithelial surface 139 
Adhesion is a complex process that results from the simultaneous interaction of fungal cell 140 
wall components with the biomolecules present on the surface of the host cell membrane. While the 141 
fungal cell wall is composed of proteins and carbohydrates (chitin, glucan and mannans), the 142 
composition of proteins and sugars differs between yeast and hyphal morphologies. In hyphae, 143 
adhesins and proteins involved in cell wall synthesis are upregulated resulting in stronger adhesion 144 
when compared to yeast {Sandin, 1982 #5351}. 145 
While most studies investigating C. albicans adhesion have used genetic approaches, 146 
relatively little is known about the structural basis of adhesion to epithelial cells.  Hyphal regulated 147 
1 (Hyr1p), hyphal wall protein 1 (Hwp1p) and the Als proteins share a similar arrangement of 148 
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domains; a folded N-terminal domain responsible for protein-protein/ligand interaction with the 149 
host followed by a serine/threonine-rich variable tandem domain of low complexity and a 150 
C-terminal peptide sequence that covalently binds to a glycosylphosphatidylinositol (GPI) lipid 151 
anchor in the fungal cell wall {Willaert, 2018 #6765}. However, no structural information is available 152 
for Hyr1p and Hwp1p adhesins at present.  153 
The N-terminal domain of Hwp1p exhibits 40-50% amino acid sequence identity with the 154 
central and N-terminal domains of the human small-proline (SPR) family of proteins which are 155 
substrates of the transglutaminase (TGase) family of enzymes. At the interface between the C. 156 
albicans cell wall and the epithelial cell membrane, host TGases cross-link Hwp1p to lysine residues 157 
within the proteins present on the epithelial surface {Staab, 2004 #6766}.  158 
Our understanding of the structure-function relationship that enables adhesion to the host is 159 
most advanced for the Als family of adhesins {Hoyer, 2016 #5284;Cota, 2015 #6778}, which recognise 160 
and bind to a variety of structurally unrelated ligands. Such flexibility enables C. albicans to attach to 161 
surfaces with different compositions including bacterial and mammalian cells and to abiotic surfaces 162 
such as medical devices {Silva-Dias, 2015 #6767}. Numerous Als binding proteins have been 163 
identified including Streptococcus gordonii Sspb, bovine serum albumin, gp96, collagen, laminin, 164 
casein, fibrinogen, human and equine ferritin and the human epidermal growth factor receptors 165 
EGFR/HER1 and HER2, fibronectin, E-cadherin and N-cadherin {Gaur, 2002 #6761;Gaur, 2004 166 
#6768;Sheppard, 2004 #6769;Phan, 2007 #5204;Almeida, 2008 #5363;Liu, 2011 #6770;Zhu, 2012 #5617}.  167 
An X-ray crystal structure of the N-terminal domain of an allelic variant of Als9p 168 
(designated Als9-2) complexed with the C-terminal region of human fibrinogen-γ reveals that the 169 
Als adhesins recognise flexible C-terminal peptides of up to six amino acids which are 170 
accommodated in an extended conformation inside a peptide binding cavity (PBC) {Salgado, 2011 171 
#6771}. A model describing how Als adhesins recognise and bind structurally unrelated ligands has 172 
been proposed in which the wide, flat PBC located in the N-terminal domain of the Als adhesin can 173 
accommodate a wide range of 6-mer peptide ligands {Lin, 2014 #6774}. Once located in the PBC, the 174 
peptide backbone of the ligand forms an extensive network of hydrogen bonds with the residues of 175 
the PBC and a salt bridge is formed between the C-terminal carboxylic acid of the incoming peptide 176 
and the positively charged side chain of a conserved lysine located at the end of the PBC. However, 177 
most transmembrane-spanning proteins typically have their free C-termini located on the 178 
intracellular face of the plasma membrane, rendering them inaccessible to the PBC of Als adhesins. 179 
To mitigate this issue, a mechanism was proposed in which secretion of fungal proteinases enables 180 
limited proteolytic digestion of the extracellular regions of membrane-associated host proteins, 181 
liberating free C-termini on the extracellular face of the plasma membrane that may subsequently be 182 
recognised by the PBC {Hoyer, 2014 #6776}. However, it must also be noted that Als1p and Als5p are 183 
capable of binding to peptides displaying free N- or C-termini {Gaur, 2002 #6761}{Klotz, 2004 #6857}. 184 
The Als family of proteins also contain an amyloid forming region (AFR), located in the 185 
N-terminal domain. Als proteins can interact with each other via their AFR motifs to form large 186 
molecular weight clusters of Als proteins, termed nanodomains {Otoo, 2008 #6151;Lipke, 2018 #6777} 187 
which are implicated in the aggregation of C. albicans hyphae, biofilm formation and cell adhesion. 188 
Furthermore, the interaction between soluble regions of AFR motifs in Als5p results in the formation 189 
of amyloid fibers {Otoo, 2008 #6151}. Analysis of AFR motifs by nuclear magnetic resonance (NMR) 190 
spectroscopy demonstrate that Als proteins interact with each other via their AFR domains to form 191 
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Als aggregates in the absence of ligands. However, in the presence of ligands that bind to the PBC 192 
these interactions are disrupted. These findings highlight that ligand binding and Als-Als 193 
aggregation are mechanistically distinct. Disruption of the PBC but not the AFR results in decreased 194 
fungal adhesion to the commensal bacterium S. gordonii, suggesting that the PBC of Als3p plays a 195 
primary role in mediating the interaction between C. albicans and microbial cells whereas the AFR 196 
motif is necessary for Als-Als clustering in the absence of Als ligands {Lin, 2014 #6774}. 197 
 198 
4. The commensal relationship with the host 199 
C. albicans is exquisitely adapted to life in the host as a commensal, particularly in the 200 
gastrointestinal tract. This continually evolving commensal relationship between C. albicans and the 201 
human body is typified by asymptomatic carriage. While commensal colonization of mucosal 202 
surfaces is often associated with yeast rather than hyphae, both morphologies have been observed to 203 
colonise the murine gastrointestinal tract {Witchley, 2019 #6849}. 204 
 Mouse models of gastrointestinal colonisation demonstrate that C. albicans can stably 205 
colonise the gastrointestinal tract in a little as three days {Prieto, 2015 #6392}. The mitogen-activated 206 
protein kinase Hog1p confers adaptation to oxidative and osmotic stress, and is essential for 207 
gastrointestinal colonisation {Prieto, 2014 #6403} while numerous transcriptional regulators 208 
including Tye7p, Lys144p, Hms1p, Rtg1p, Rgt3p and ORF19.3625 play a significant role in 209 
colonization {Perez, 2013 #6401}.  210 
Recently, significant advances in our understanding of the fine balance between beneficial 211 
and detrimental anti-fungal immune responses have been made. Commensal colonisation of the 212 
host intestine drives the expansion of systemic Th17 CD4+ T cells that, together with IL-17 responsive 213 
neutrophils, protect against invasive infection {Shao, 2019 #6851}. However, colonization was 214 
observed to exacerbate susceptibility to allergic airway inflammation {Shao, 2019 #6851}. Indeed, the 215 
process of intestinal inflammation drives the expansion of C. albicans-specific Th17 cells and a pool of 216 
Th17 cells that exhibit cross-reactivity to Aspergillus fumigatus in patients with airway inflammation 217 
and acute allergic bronchopulmonary aspergilosis {Bacher, 2019 #6853}, establishing a link between 218 
protective immunity in the gut and immune pathology in the lung {Bacher, 2019 #6853}{Shao, 2019 219 
#6851}. 220 
The C. albicans transcription factor enhanced filamentous growth 1 (Efg1p) is a major 221 
regulator of commensal colonisation in healthy and immune compromised mice. In vivo competition 222 
experiments between wild type C. albicans and an efg1Δ/Δ null mutant strain in healthy (immune 223 
competent) mice demonstrate that fungi lacking efg1 have an increased propensity to colonise the 224 
gastrointestinal tract at early time points (up to 24 h) which is not sustained at later time points 225 
{Pierce, 2012 #6404}. EFG1 gene expression in wild type C. albicans isolated from the caecum or ileum 226 
of wild type BALB/c mice was low during the initial stages of gastrointestinal colonization (within 3 227 
d) but increased over time up to 18 d. In contrast, EFG1 gene expression in wild type C. albicans 228 
isolated from T-cell deficient nu/nu mice was consistently low at all time points analysed {Pierce, 229 
2012 #6404}. Thus, variations in the level of EFG1 expression within colonising populations of fungi 230 
are proposed to reflect an adaptation to the degree of fitness between healthy and compromised 231 
hosts, facilitating the transition from commensal to pathogenic behavior {Pierce, 2012 #6404}. 232 
Indeed, EFG1 gene dosage has a profound effect on phenotypic plasticity and C. albicans 233 
commensalism {Liang, 2019 #6850}. Many clinical isolates of C. albicans are hemizygous for EFG1 234 
Pathogens 2019, 8, x FOR PEER REVIEW 7 of 16 
 
(EFG1/efg1) and undergo a transition from the white to gray state via a mechanism that involves loss 235 
of EFG1 function, resulting in enhanced fitness in the gastrointestinal tract {Liang, 2019 #6850}. 236 
C. albicans is inordinately responsive to the stresses it frequently encounters and has evolved 237 
to use these environmental cues as a means to persist in the host. Passage of C. albicans through the 238 
murine gastrointestinal tract induces a white-opaque regulator (Wor1p)-dependent switch to the 239 
gastrointestinal induced transition (GUT) phenotype that promotes commensalism {Pande, 2013 240 
#6385}, while C. albicans opaque cells exhibit increased colonisation of skin compared to white cells 241 
{Xie, 2013 #6387}. 242 
Very recently, competitive infection experiments between wild type C. albicans and a large 243 
panel of null mutant strains in a murine model of gastrointestinal colonisation have revealed that the 244 
hyphal gene network that promotes virulence causes an inhibition of commensal fitness {Witchley, 245 
2019 #6849}. Five transcription factor null mutants (brg1Δ/Δ, efg1Δ/Δ, rob1Δ/Δ, tec1Δ/Δ and ume6Δ/Δ) 246 
exhibited enhanced colonisation fitness when compared to an isogenic wild type control strain 247 
suggesting that commensal fitness in the gut is inversely related to the expression of genes required 248 
for the coordination of morphogenesis {Witchley, 2019 #6849}. Notably, Ume6p-mediated inhibition 249 
of gut colonization required the activation of the secreted aspartic proteinase Sap6p and, to a lesser 250 
extent, Hyr1p {Witchley, 2019 #6849}. 251 
The apparent antagonism between hyphal growth and commensalism is further 252 
underpinned by the observation that serial passage of C. albicans through the murine gastrointestinal 253 
tract promotes adaptive evolution that results in the loss of hypha-forming ability in the absence of a 254 
competitive microbiota {Tso, 2018 #6848}. Gut-evolved C. albicans strains that lost the ability to form 255 
hyphae exhibited reduced virulence in vitro and in vivo. Strikingly, mice “primed” with evolved C. 256 
albicans received substantial innate protection against systemic infection with Aspergillus fumigatus, 257 
Staphylococcus aureus and Pseudomonas aeruginosa {Tso, 2018 #6848}. 258 
 259 
5. Invasion of the mucosal surface 260 
Mucosal internalisation of C. albicans requires a number of host and pathogen-derived 261 
factors but remains incompletely understood. There are two main mechanisms of C. albicans 262 
internalisation. Induced endocytosis describes a process where C. albicans remains completely 263 
passive during its uptake into host cells, such that metabolically non-viable fungi are still 264 
endocytosed. The mechanism is clathrin-dependent and requires actin cytoskeleton remodelling 265 
{Moreno-Ruiz, 2009 #5488}. Induced endocytosis can be instigated by the binding of host E-cadherin 266 
or EGFR/Her2 complexes to the fungal invasins Ssa1p or Als3p. Studies show that latex beads coated 267 
with the N-terminal region of Als3p are successfully internalised {Phan, 2007 #5204} while inhibition 268 
of EGFR/Her2 activity significantly reduces the severity of oropharyngeal candidiasis (OPC) {Zhu, 269 
2012 #5617}. Other proteins with a role in C. albicans endocytosis include host GTPases and zonula 270 
occludens-1 which are associated with actin remodelling during infection {Atre, 2009 #5510}, the aryl 271 
hydrocarbon receptor (AhR), thought to govern EGFR-induced endocytosis {Solis, 2017 #6597}, 272 
platelet derived growth factor BB (PDGF BB) and neural precursor cell expressed developmentally 273 
down-regulated protein 9 (NEDD9), which are important for host-induced uptake of fungus {Liu, 274 
2015 #5896}. The major factors that contribute to the process of induced endocytosis of C. albicans 275 
hyphae are depicted in Figure 1C.  276 
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Active penetration by C. albicans results in direct breach of the epithelium, with hyphae 277 
extending through individual epithelial cells or between them. Unlike induced endocytosis, this 278 
process is dependent on C. albicans morphology, where the maintenance of turgor pressure and 279 
continued extension of hyphal tips play important roles. Although the presence of C. albicans in the 280 
gastrointestinal tract is closely associated with commensal carriage, translocation across the 281 
gastrointestinal mucosa positively correlates with systemic infection {Nucci, 2001 #6806;Bougnoux, 282 
2006 #6807;Gouba, 2015 #6808}. Recent research has demonstrated that the predominant route of 283 
gastrointestinal translocation by C. albicans is transcellular rather than paracellular (occurring 284 
through epithelial cells as opposed to between them), a process that is facilitated by the peptide toxin 285 
candidalysin {Allert, 2018 #6278}. Additionally, fungal secreted aspartic proteases 2 (Sap2p) and 286 
Sap5p, which degrade gastrointestinal mucins {Colina, 1996 #5296} and E-cadherin {Villar, 2007 287 
#5352}, respectively, may also facilitate the translocation of C. albicans across the epithelium. Though 288 
active penetration was considered to be the only mechanism of C. albicans internalisation at the 289 
gastrointestinal epithelium {Dalle, 2010 #5515}, recent evidence suggests that a host facilitated 290 
method may also occur that is dependent on gut M cells {Albac, 2016 #6598}. Perhaps 291 
unsurprisingly, many of the host proteins that govern fungal invasion possess functions in 292 
maintaining the epithelium highlighting the significance of epithelial barrier integrity in protection 293 
against C. albicans infection {Goyer, 2016 #6599}. 294 
 295 
6. Epithelial recognition of C. albicans     296 
The first step in developing an innate immune response against C. albicans is host 297 
recognition. The cells that comprise mucosal barriers express pattern recognition receptors (PRRs) 298 
that recognise pathogen-associated molecular patterns (PAMPs) such as fungal cell wall components 299 
present on yeast and hyphal cells {Pappas, 2018 #6601}. There are three main classes of PRR 300 
expressed in innate myeloid cells associated with fungal infections: the toll-like receptors (TLRs), the 301 
C-type lectin receptors (CLRs) and the NOD-like receptors (NLRs). Of these, TLRs and CLRs are 302 
expressed in epithelial cells {Gow, 2011 #6602;Underhill, 2015 #6603;Naglik, 2017 #6163}. TLRs 303 
comprise an extracellular domain rich in leucine repeats required for recognition of microbial 304 
structures, and a cytoplasmic Toll/IL-1 receptor (TIR) domain that is responsible for intracellular 305 
signalling {Ozinsky, 2000 #6605;Bellocchio, 2004 #6607;Gow, 2011 #6602}. Of all TLRs, only TLR5 and 306 
TLR7 are not detectable in human buccal epithelial cells from healthy donors. Epithelial cells interact 307 
with C. albicans through TLR1-4 and TLR6 {Netea, 2006 #6608;Weindl, 2007 #4437;Weindl, 2010 308 
#6609;Pinheiro, 2018 #6596}, with TLR4 being induced during oral candidiasis and TLR2 during 309 
vulvovaginal candidiasis {Weindl, 2007 #4437;Rosentul, 2014 #6610}.  310 
CLRs recognise polysaccharide structures on microbes and are probably the most important 311 
receptors that mediate fungal recognition in macrophages, dendritic cells and neutrophils. Dectin-1 312 
is a β-glucan receptor and constitutes one of the major CLRs in myeloid cells found to be important 313 
in systemic infections {Brown, 2001 #6137;Taylor, 2007 #804;Reid, 2009 #6138}. Although dectin-1 can 314 
bind to the β-glucan present on yeast phase C. albicans {Swidergall, 2017 #5882}, infection of TR146 315 
epithelial cells with C. albicans for 24 h resulted in a downregulation of dectin-1 gene expression 316 
{Moyes, 2014 #4418}. Indeed, dectin-1 is thought to play only a minor role in the oral epithelial 317 
response to C. albicans {Weindl, 2010 #6609}. In contrast, a nonsense mutation in dectin-1 (Y238STOP) 318 
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is associated with recurrent vulvovaginal candidiasis (RVVC) {Ferwerda, 2009 #6854} suggesting a 319 
protective role for dectin-1 in the vaginal response to C. albicans. 320 
Recently, the ephrin type-A receptor 2 (EphA2) was identified as a non-classical epithelial 321 
PRR that recognises the β-glucans present on C. albicans yeast and hyphae {Swidergall, 2017 #5882}. 322 
Activation of EphA2 was observed within 15 min in response to yeast phase C. albicans and 90 min 323 
for hyphae, with subsequent activation of signal transducer and activator of transcription 3 (STAT3), 324 
mitogen-activated protein kinase (MAPK) and nuclear factor kappa-light-chain-enhancer of 325 
activated B cells (NF-κB) signalling and a proinflammatory and antifungal response at 24 h 326 
{Swidergall, 2017 #5882}. These findings suggest a role for EphA2 in the initial interaction between C. 327 
albicans and epithelial cells, most likely to prime mucosal tissues for subsequent induction of 328 
appropriate immune responses to hyphal factors release later during mucosal infection.  329 
Epithelial cells discriminate between harmless commensalism and invasive hyphae via a 330 
biphasic activation of the MAPK immune pathway {Moyes, 2010 #1260;Moyes, 2011 #4409}. 331 
Recognition of commensal yeast comprises the first phase of the biphasic epithelial response, 332 
resulting in a weak activation of the NF-κB pathway, the phosphoinositide 3-kinase (PI3K) pathway, 333 
and the c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinases (ERK1/2) and p38 334 
MAPK pathways {Moyes, 2010 #1260;Moyes, 2015 #4420}. Activation of the NF-κB pathway by 335 
fungal cell wall components (e.g. mannan, chitin, β-glucan) is sustained during commensal 336 
colonization, while transient MAPK pathway activity results in the activation of the transcriptional 337 
regulator c-Jun in the absence of significant hyphal burdens {Moyes, 2010 #1260}. Relatively little is 338 
known about the epithelial c-Jun response to C. albicans yeast, only that it comprises the 339 
predominant epithelial response to the yeast morphology of C. albicans, and may therefore be 340 
considered as a host response to commensal colonization {Moyes, 2010 #1260}. Notably, the weak 341 
activation of NF-κB, MAPK and PI3K pathways does not result in epithelial damage or the induction 342 
of a pro-inflammatory response {Moyes, 2010 #1260}. 343 
In contrast, elevated burdens of invasive hyphae trigger the second phase of the biphasic 344 
epithelial response, which is characterized by a strong, sustained activation of the p38, JNK and 345 
ERK1/2 MAPK pathways, resulting in c-Fos activation via p38 and the subsequent release of 346 
proinflammatory cytokines (GM-CSF, G-CSF, IL-6, IL-1α, IL-1β, IL-36) and the recruitment of innate 347 
immune cells, including TCRαβ(+) cells, macrophages and neutrophils {Moyes, 2010 348 
#1260;Gladiator, 2013 #6094;Naglik, 2017 #6163;Verma, 2017 #5904;Verma, 2018 #6291}. The MAPK 349 
phosphatase-1 (MKP1) is also activated via MEK1/2-ERK1/2 and acts as a negative regulator of 350 
MAPK signaling by dephosphorylating p38 and JNK {Liu, 2007 #6612;Moyes, 2015 #4420}. Together, 351 
the ERK/MKP1 and p38/c-Fos signaling pathways alert surrounding tissues to the presence of 352 
invasive C. albicans hyphae, a process which has come to be known as the “danger response” 353 
{Moyes, 2010 #1260}.  354 
Recently, it was demonstrated that the activation of the epithelial danger response and the 355 
damage caused to epithelial cells during C. albicans infection is driven by candidalysin; a cytolytic 356 
peptide toxin secreted from C. albicans hyphae {Moyes, 2016 #4459;Richardson, 2017 #5903}. 357 
Candidalysin is encoded by the extent of cell elongation 1 (ECE1) gene and is derived from 358 
sequential proteolytic cleavage of its parent protein Ece1p by kexin-like proteinases {Moyes, 2016 359 
#4459;Richardson, 2018 #6275}. C. albicans mutants lacking ECE1 or candidalysin form hyphae and 360 
penetrate epithelial cells normally, but do not activate a pro-inflammatory response or cause 361 
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epithelial damage. During mucosal infection, it is proposed that candidalysin accumulates in an 362 
invasion “pocket” created by the invading hyphae. Once the concentration of candidalysin is 363 
sufficiently high it causes calcium influx, release of lactate dehydrogenase and membrane 364 
destabilization; all of which are characteristics of several microbial toxins {Bischofberger, 2012 365 
#6645;Moyes, 2016 #4459}. Thus, while epithelial recognition of C. albicans β-glucan is mediated 366 
through the non-classical PRR EphA2 {Swidergall, 2017 #5882}, it is the recognition of candidalysin 367 
activity that drives the host proinflammatory response {Moyes, 2016 #4459}. The epithelial receptors 368 
with known ligands involved in the recognition of C. albicans are presented in Table 1. 369 
 370 
Table 1. Epithelial receptor-ligand pairings involved in recognition of C. albicans. 371 
Receptor Ligand Reference 













Approximately 75% of females will experience an episode of vulvovaginal candidiasis 374 
(VVC) in their lifetime {Peters, 2014 #5845}, while approximately 9% will suffer from recurrent VVC 375 
{Foxman, 2013 #956}. The symptoms of VVC (itching, burning, pain, discharge) are associated with 376 
the recruitment of neutrophils into the vaginal lumen {Fidel, 2004 #683}. Recent advances have 377 
demonstrated that the immune pathology associated with VVC is driven by the secretion of 378 
candidalysin from C. albicans hyphae {Richardson, 2017 #5903} and the presence of heparan sulphate, 379 
which blocks the interaction between neutrophil Mac1 and C. albicans Pra1p required for fungal 380 
killing {Yano, 2017 #6866}{Yano, 2018 #6867}. 381 
 382 
7. Epithelial responses to C. albicans 383 
Mucosal surfaces secrete numerous host defence peptides as part of the innate immune 384 
response to C. albicans. The most prominent of these include the defensins, cathelicidin, lactoferrin, 385 
histatin-5 and the alarmins S100A8 and S100A9 {Conti, 2009 #718;Swidergall, 2017 #6614;Richardson, 386 
2018 #6615}. Defensins are cysteine-rich peptides that can be divided into two families: the 387 
α-defensins, which are mainly secreted by neutrophils, and the β-defensins, which are produced 388 
from epithelial cells {Diamond, 2011 #6618}. Recently, however, α-defensin 6 secreted by human 389 
intestinal epithelial cells has been shown to inhibit C. albicans invasion and biofilm formation 390 
{Chairatana, 2017 #6004}. In humans, four β-defensins are expressed in epithelial cells: hBD-1, 391 
hBD-2, hBD-3 and hBD-4 {Diamond, 2011 #6618;Hua, 2014 #6624}. While hBD-1 and hBD-4 are 392 
constitutively expressed, hBD-2 and hBD-3 are present at low concentrations and are strongly 393 
induced in response to infection or stress {Diamond, 2011 #6618}. HBD-2 and hBD-3 are found in the 394 
human buccal epithelium {Sawaki, 2002 #6625} and are preferentially induced by C. albicans hyphae 395 
rather than yeast cells {Feng, 2005 #1574}. The antifungal activity of both of these defensins requires 396 
binding to the fungal invasin Ssa1p {Vylkova, 2006 #6627}. Defensins can also act as 397 
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chemoattractants for T cells, DCs and neutrophils {Vylkova, 2006 #6627}. Mice deficient in IL-17RA 398 
express reduced levels of mBD3 and consequently develop severe OPC {Conti, 2016 #4785}, 399 
underlining the importance of these molecules in the innate response to fungal infection. 400 
LL-37 is the only human cathelicidin identified to date and has a broad spectrum of immune 401 
functions including antibacterial action and the ability to induce chemokines. It is a cationic 402 
antimicrobial peptide produced by many types of cells including epithelial cells {Hua, 2014 #6624}. 403 
LL-37 is present in the oral cavity where it inhibits the adherence of C. albicans to epithelial cells by 404 
interacting with fungal cell wall components such as mannan, chitin and glucan {Tsai, 2011 #6629}.  405 
The S100 alarmins are typically found in the cytoplasm but are released into the extracellular 406 
environment following tissue damage. A variety of cell types express S100 alarmins including 407 
polymorphonuclear neutrophils, monocytes and epithelial cells. The S100 alarmins produced by 408 
vaginal epithelial cells are implicated in the recruitment of innate cells following interaction with C. 409 
albicans {Yano, 2010 #999;Yano, 2014 #650}. Calprotectin, which constitutes a dimer of S100A8 and 410 
S100A9, inhibits C. albicans cell growth {Sohnle, 1996 #6632;Kuhbacher, 2017 #5404}. Lactoferrin also 411 
possesses antifungal activity by disrupting the C. albicans plasma membrane {Nikawa, 1993 #5984} 412 
and inducing iron deprivation {Kirkpatrick, 1971 #5994} within the fungus. Histatin-5 is a 413 
histidine-rich cationic peptide secreted by human salivary glands. This peptide interacts with the 414 
β-glucans present in the C. albicans cell wall, binds to the heat shock proteins Ssa1p/2p {Li, 2003 415 
#5996}, perturbs the fungal plasma membrane and is translocated into the cytoplasm where it 416 
disturbs the balance of cellular ions leading to toxicity {Jang, 2010 #5995}.  417 
Recent research has demonstrated that epithelial cells express the IL-17 receptor (IL-17R) 418 
which binds to IL-17 secreted by multiple lymphoid cells including γδ-T, natural killer T (NKT), 419 
innate lymphoid cell type 3 (ILC3) and TCRβ+ ‘natural’ Th17 cells (nTh17) {Conti, 2014 420 
#1256;Huppler, 2015 #6065}. From the several IL-17 isoforms, only IL-17A and IL-17F seem to be 421 
important in mediating antifungal immunity {Huppler, 2015 #6065;Richardson, 2018 #6615}. These 422 
isoforms trigger the release of the neutrophil activating chemokine G-CSF and β-defensin-1 and -3 423 
from epithelial cells in oral tissue and the release of histatins from the salivary glands during OPC 424 
{Conti, 2009 #718;Tomalka, 2015 #6018}. Mice lacking IL-17R are highly susceptible to OPC {Conti, 425 
2014 #1256}. However, human patients deficient in IL-17 secretion or signalling owing to mutations 426 
in IL-17F or IL17RA show high susceptibility to mucosal but not invasive candidiasis suggesting 427 
that, in humans, Th17 cell responses are mainly necessary for mucosal antifungal responses {Liu, 428 
2011 #445;Puel, 2011 #174;Netea, 2015 #4746}. Factors involved in the epithelial response to C. albicans 429 
are summarized in Table 2. 430 
 431 
Table 2. Factors involved in the host epithelial response to C. albicans. 432 
Factor Target Cell/tissue Reference 
α-defensin 6 Invasion/biofilm formation Intestinal ECs 
{Chairatana, 
2017 #6004} 
Murine β-defensin 1 Reduces mucosal infection Oral cavity 
{Tomalka, 2015 
#6018} 
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Cathelicidin Fungal adherence Oral cavity 
{Tsai, 2011 
#6629} 




Calprotectin Fungal cell growth In vitro 
{Sohnle, 1996 
#6632} 
Lactoferrin Plasma membrane In vitro 
{Nikawa, 1993 
#5984} 






8. Secreted fungal factors 435 
In order to persist in the host C. albicans must overcome (or avoid) the host immune response 436 
and the various challenges posed by the host niche. C. albicans secretes 225 proteins which facilitate 437 
tissue invasion, immune evasion, nutrient acquisition and organ damage {Sorgo, 2013 #6633}. Many 438 
of these secreted proteins are enzymes including lipases, phospholipases and Saps {Cauchie, 2017 439 
#6634}, which have different substrate specificities and pH optimums {da Silva Dantas, 2016 #6756}. 440 
The best studied of these secreted enzymes are the Saps, which comprise Sap1p to Sap10p {Sorgo, 441 
2013 #6633;Naglik, 2003 #166}. Sap1-8p are secreted into the extracellular milieu while Sap9p and 442 
Sap10p remain anchored on the cell membrane {Albrecht, 2006 #4603}. Sap2p and Sap6p stimulate 443 
neutrophil chemotaxis during vaginitis {Gabrielli, 2016 #6037}. 444 
Collectively, the Saps degrade a wide range of host factors including E‐cadherin and several 445 
involved in the innate and adaptive immune responses (e.g. complement, histatin-5, antibodies), 446 
allowing C. albicans to combat host immune defences {Naglik, 2003 #166;Cassone, 2015 #6635}. The 447 
amyloidogenic regions within Sap6p contribute to fungal aggregation by binding to zinc and 448 
Zap1p-regulated proteins on the hypha surface {Kumar, 2017 #6826}. Conflicting reports surround 449 
the ability of Saps to cause damage to the oral epithelium; while the application of a Sap inhibitor to 450 
C. albicans reduced levels of epithelial damage {Naglik, 2008 #4593}, studies with Sap deletion 451 
mutant strains did not recapitulate this effect {Lermann, 2008 #4740}.  452 
Although relatively little is known about secreted lipases and phospholipases in comparison 453 
to the Saps, both classes of enzyme are associated with C. albicans virulence. Expression of 454 
phospholipases is positively correlated with increased epithelial adherence and pathogenicity 455 
{Barrett-Bee, 1985 #6810;Ibrahim, 1995 #6811}. Notably, secretion of phospholipase B1 (Plb1p) 456 
contributes to epithelial penetrance and gastrointestinal translocation {Leidich, 1998 457 
#6812;Mukherjee, 2001 #6813}, while a C. albicans pld1 null mutant forms hyphae in vivo, can adhere 458 
to and colonize the murine alimentary tract, but is unable to penetrate the epithelium {Dolan, 2004 459 
#6814}. 460 
C. albicans encodes ten lipases designated Lip1p {Fu, 1997 #4691} and Lip2-10p {Hube, 2000 461 
#6638} which are differentially expressed during mucosal colonization and infection {Schofield, 2005 462 
#4705}. Expression of LIP1-10 is detectable in a reconstituted human oral epithelium infection model 463 
after 48 h {Stehr, 2004 #4708} while analysis of C. albicans isolated from the saliva of oral candidiasis 464 
patients demonstrates that all lipases except LIP10 were expressed across the patient cohort {Stehr, 465 
2004 #4708}. 466 
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The host mucosa secretes an array of antimicrobial compounds that function to clear 467 
invading pathogens. In response to this secreted armory, C. albicans can also produce an arsenal of 468 
factors to protect itself from this secreted host response. While not secreted per se, Msb2p is a C. 469 
albicans cell surface protein that is shed into the extracellular environment where it confers 470 
broad-range protection against numerous antimicrobials including LL-37, hBD-1 and histatin-5 471 
{Swidergall, 2013 #6395}. Histatin-5 is also degraded by Sap9p {Meiller, 2009 #6396} and is actively 472 
effluxed from the fungal cell by the polyamine transporter Flu1p {Li, 2013 #6399}. The secreted 473 
factors that contribute to C. albicans pathogenicity are depicted in Figure 1D. 474 
 475 
9. Acquisition of micronutrients 476 
While often discussed in the context of systemic infection, microbial acquisition of host 477 
micronutrients is also important at mucosal surfaces. The concentration of zinc, copper and iron in 478 
whole saliva is highly variable between individuals and is influenced by numerous factors including 479 
diet, gender, age, general health and lifestyle choices such as smoking {Kode, 2013 #6859}{Kim, 2010 480 
#6864}{Chicharro, 1999 #6860}{Olmez, 1988 #6862}. 481 
Although the gastrointestinal tract receives a steady supply of dietary iron, micronutrients 482 
such as zinc are subject to diet-independent changes in availability, for instance, by neutrophil 483 
mediated calprotectin-dependent sequestration during gastrointestinal inflammation {Liu, 2012 484 
#6865}. Relatively little is known about the concentration of micronutrients at the vaginal mucosa. 485 
Throughout the course of host-microbe co-evolution, the human host has evolved to withhold 486 
specific nutrients from microbes as a defence strategy designed to curtail microbial growth and 487 
persistence. To thwart such defences, C. albicans has evolved to express and regulate numerous 488 
micronutrient acquisition systems in order to persist in the hostile environment of the human body, 489 
whether it be as a commensal or pathogen. 490 
 491 
9.1 Assimilation of zinc 492 
Current research is now unveiling the importance of zinc in the complex relationship 493 
between C. albicans and the human host. Under condition in which nutritional immunity is imposed, 494 
C. albicans remains capable of acquiring zinc from the host. The pH-regulated antigen-1 (Pra1p) is a 495 
secreted zinc-binding “zincophore” that harvests zinc from the host environment before 496 
re-associating with the fungal cell and the co-expressed zinc zip-transporter Zrt1p {Citiulo, 2012 497 
#4784}. Sap6p can also bind zinc and is required for zinc uptake and fungal growth in low zinc 498 
environments {Kumar, 2017 #6826}. 499 
Zinc homeostasis in C. albicans is regulated by the transcriptional activator Zap1p which 500 
controls the expression of several genes including the zinc transporters ZRT1-3 and the vacuolar zinc 501 
importer ZRC1 {Kim, 2008 #6847}{Nobile, 2009 #6458}. Conditions of zinc limitation drive the 502 
formation of the so-called “Goliath” phenotype, in which C. albicans yeast cells become enlarged and 503 
exhibit hyper-adherence to polystyrene {Malavia, 2017 #6123}. C. albicans Zrt2p is essential for zinc 504 
uptake at acidic pH {Crawford, 2018 #6785}. Cellular import of zinc is mediated by Zrt1p/Zrt2p 505 
while Zrc1p functions during storage of zinc in vesicle-like “zincosomes” {Crawford, 2018 #6785}. 506 
The major factors required for zinc acquisition from the host are depicted in Figure 2A and B. 507 
 508 
 509 




Figure 2. Acquisition of micronutrients by Candida albicans. A) C. albicans uses the secreted 512 
zincophore Pra1p to bind free zinc and scavenge zinc from zinc-containing host proteins. Once zinc 513 
is acquired it is imported into the cell by the zinc transporter Zrt1p. Zrt2p is also capable of 514 
importing zinc and is essential for zinc uptake at acidic pH. B) The secreted aspartic proteinase 515 
Sap6p is also a zincophore capable of binding and importing zinc. C) Als3p can bind to host ferritin 516 
to release ferric and ferrous ions that are reduced and oxidised by ferric reductases and ferric 517 
oxidases respectively. C. albicans can also acquire free iron which is imported into the cell by Ftr1p. 518 
D) The haemolytic activity of C. albicans liberates haemoglobin from blood. Haemoglobin/haem are 519 
bound by the haemoglobin receptor Rbt5p and by Pga7p and endocytosed into the cell. E) C. albicans 520 
can also acquire iron by scavenging siderophores. The ferrichrome transporter Sit1p is used to 521 
import ferric ions. F) Import of copper is mediated by the copper transporter Ctr1p. 522 
 523 
9.2 Iron uptake 524 
C. albicans uses three distinct iron uptake systems; haemoglobin uptake, the reductive iron uptake 525 
system and by scavenging host siderophores {Moors, 1992 #6658;Ramanan, 2000 #6661;Lesuisse, 526 
2002 #6662;Heymann, 2002 #6674}. C. albicans can lyse erythrocytes to release haemoglobin from 527 
blood {Manns, 1994 #6680;Watanabe, 1999 #6797;Luo, 2001 #6796;Moyes, 2016 #4459}, which is 528 
subsequently bound by the haemoglobin receptor Rbt5p (and its homolog Rbt51p), Pga7p and the 529 
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secreted haemophore Csa2p {Weissman, 2004 #6096;Nasser, 2016 #6683;Sorgo, 2010 #6686;Kuznets, 530 
2014 #6685}. A coordinated haem “acquisition relay” between Rbt5p and Pga7p facilitates the 531 
transport of haem from the extracellular environment into vacuoles of the endocytic pathway 532 
{Weissman, 2008 #6097;Kuznets, 2014 #6685} where it can be further processed for use. 533 
C. albicans uses a reductive uptake system to acquire iron from ferritin, transferrin {Knight, 2005 534 
#6815} and ferric ions. Although a receptor for transferrin has not yet been identified, Als3p exhibits 535 
ferritin binding activity in addition to its role as an adhesin and invasin {Almeida, 2008 #5363}. To 536 
utilize the iron found in transferrin, the membrane-associated ferric reductases Cfl1p and Fre10p 537 
reduce Fe3+ to Fe2+ {Hammacott, 2000 #6665}{Knight, 2005 #6815}, which is transported into the cell 538 
via a complex comprising an iron permease and a multicopper oxidase {Mamouei, 2017 #6666}. C. 539 
albicans possesses four iron permeases; the plasma membrane associated Ftr1p and Ftr2p and the 540 
vacuolar associated Fth1p and Fth2p {Ramanan, 2000 #6661;Mamouei, 2017 #6666}, and five genes 541 
encoding iron ferroxidases, all of which are multicopper oxidases {Knight, 2002 #6819;Eck, 1999 542 
#6667;Mamouei, 2017 #6666;Ziegler, 2011 #6668}. It is predicted that as many as twenty possible iron 543 
transporter complexes may be formed to facilitate iron uptake {Mamouei, 2017 #6666}. The 544 
importance of copper in the process of high affinity iron transport is highlighted by gene deletion 545 
analysis of the copper-transporting P-type ATPase Ccc2p {Weissman, 2002 #6802}. A C. albicans 546 
ccc2Δ/Δ null mutant is unable to use haem as an iron source but may continue to acquire iron from 547 
haemin and haemoglobin {Weissman, 2002 #6802}. 548 
C. albicans uses the ferrichrome siderophore importer protein Sit1p to scavenge siderophores from 549 
bacteria and other fungi. Such behavior is termed ‘iron parasitism’ and is well documented in 550 
numerous microbes {Heymann, 2002 #6674;Hu, 2002 #6675;Wandersman, 2004 #6676}. Sit1p is 551 
required for epithelial invasion but is dispensable for disseminated infection in vivo {Heymann, 2002 552 
#6674}. The major iron uptake systems of C. albicans are summarised in Figure 2C-E. 553 
The balance between iron uptake and the avoidance of iron-related toxicity is addressed by an 554 
elegant tripartite circuit comprising the transcriptional activator Sef1p which promotes iron uptake 555 
together with Sfu1p and Hap34p which repress transcriptional activation of iron-uptake and 556 
utilization genes, respectively {Chen, 2011 #6402}. Together, these factors confer resistance to iron 557 
depletion in the systemic compartment while enabling the fungus to avoid iron toxicity during 558 
commensal colonization of the gastrointestinal tract {Chen, 2011 #6402}. 559 
 560 
9.3 Copper 561 
 C. albicans uses the transcriptional activator Mac1p to activate expression of the high-affinity 562 
copper transporter Ctr1p in copper replete environments {Marvin, 2003 #6710;Marvin, 2004 #6711}. 563 
Once in the cell, Cu+ is rapidly bound to intracellular chaperone proteins before being incorporated 564 
into copper requiring proteins. Copper is also required for efficient iron uptake as it is incorporated 565 
into the multicopper oxidases of C. albicans and a ctr1 null mutant is unable to grow under 566 
conditions of copper or iron limitation {Marvin, 2003 #6710;Marvin, 2004 #6711}. C. albicans can resist 567 
the toxicity associated with the intracellular accumulation of copper ions by activating the copper 568 
resistance determinant gene CRD1 (also known as CRP1) encoding a P1-type ATPase copper 569 
extrusion pump that removes excess copper ions from the cell {Riggle, 2000 #6713;Weissman, 2000 570 
#6804}. A C. albicans crd1 null mutant is sensitive to exogenous sources of copper, silver and 571 
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cadmium, suggesting a degree of function promiscuity towards the efflux of metal ions {Riggle, 2000 572 
#6713}.  573 
C. albicans Sur7p is a component of the membrane compartment containing Can1 (MCC) plasma 574 
membrane sub-domain required for appropriate morphogenesis, cell wall synthesis, localisation of 575 
actin and responses to cell wall stress {Alvarez, 2009 #6839}{Alvarez, 2008 #6841}{Bernardo, 2010 576 
#6842}{Wang, 2011 #6844}. Deletion of SUR7 results in an increased sensitivity to copper {Douglas, 577 
2012 #6845}. More recently, the architecture of the fungal plasma membrane has been show to play 578 
an important role in resistance to copper toxicity. The plasma membrane of C. albicans pil1Δ/Δ, 579 
lsp1Δ/Δ, rvs161Δ/Δ, rvs167Δ/Δ, arp2Δ/Δ and arp3Δ/Δ mutants are more readily permeabilised by 580 
copper and are more susceptible to copper-mediated killing {Douglas, 2019 #6838}. Copper uptake 581 
from the host is depicted in Figure 2F. 582 
 583 
10. Conclusions 584 
The mucosal surfaces of the human body have a long-established relationship with C. albicans that 585 
continues to evolve. Throughout this evolving relationship, fungal adaptation and the mucosal 586 
immune response have provided a fulcrum about which the balance between commensalism and 587 
pathogenicity is determined. Although research often highlights the importance of individual 588 
factors to mucosal commensalism and pathogenesis, it must be stressed that both are multifactorial 589 
processes that draw heavily upon the combined biological output of numerous molecules. As 590 
research continues to explore the interface between fungal adaptation and the host mucosal 591 
response, our understanding of the events that determine commensalism and pathogenicity at 592 
mucosal surfaces will become ever clearer. 593 
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